Pharyngeal Electrical Stimulation Recognized as Important Tool for Post-Stroke Recovery in New American Heart Association and American Stroke Association Guideline

A new clinical guideline released by the American Heart Association/American Stroke Association recognizes pharyngeal electrical stimulation (PES) as a valuable tool in helping stroke patients regain swallowing control. The guideline, published January 27, 2026, specifically acknowledges the role of PES in accelerating recovery from dysphagia – the medical term for difficulty swallowing – following an ischemic stroke.

Understanding the Impact of Dysphagia

Dysphagia is a common and serious complication after a stroke, affecting approximately 45% of patients. It can lead to significant health risks, including a three-times higher chance of developing pneumonia and a seven-times increased need for a permanent feeding tube. Patients experiencing dysphagia also face an eight-times greater risk of death within three months, and are more likely to require hospital readmission.

What is Phagenyx?

Phagenyx, developed by Phagenesis, is the only commercially available system delivering PES to patients. The Phagenyx^® System uses electrical stimulation to activate nerves in the throat, helping to retrain the brain and restore the ability to swallow safely and effectively. The system is indicated for severe post-stroke dysphagia in the United States and is CE-marked in Europe for neurogenic dysphagia from various neurological conditions.

Did You Know? Phagenyx is supported by over 30 peer-reviewed publications, including 9 randomized controlled trials and 13 mechanistic studies.

Guideline Recommendations for PES

The 2026 AHA/ASA guideline provides specific recommendations for using PES in stroke patients with dysphagia. It states that PES can be beneficial in reducing the severity of swallowing difficulties and lowering the risk of aspiration – when food or liquid enters the lungs. The guideline also recommends PES for patients with severe stroke who require tracheotomy and mechanical ventilation, potentially speeding up the process of decannulation, or removal of the breathing tube.

Expert Insight: The inclusion of PES in these guidelines represents a significant step forward in stroke care, providing clinicians with a validated therapeutic option to improve patient outcomes and quality of life.

Looking Ahead

The formal recognition of PES by the AHA/ASA could lead to wider adoption of the therapy in stroke rehabilitation programs. Clinicians may increasingly integrate Phagenyx into routine care, potentially reducing complications and improving patients’ ability to eat and drink independently. Further research could explore the long-term benefits of PES and its application to other neurological conditions causing dysphagia. It is also possible that increased awareness of dysphagia as a treatable condition will lead to earlier intervention and improved patient outcomes.

Frequently Asked Questions

What is pharyngeal electrical stimulation (PES)?

PES involves applying electrical stimulation to the sensory nerves in the throat to restore the brain’s control of swallowing function.

What are the potential benefits of PES for stroke patients?

PES can be beneficial to reduce dysphagia severity, decrease the risk of aspiration, and expedite decannulation in patients requiring tracheotomy and mechanical ventilation.

Who is Phagenesis?

Phagenesis is a medical technology company that developed the Phagenyx^® System, a clinically validated neuromodulation therapy for neurogenic dysphagia.

How might advancements in technologies like Phagenyx change the landscape of stroke recovery in the coming years?